Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5739-5745
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5739
Table 1 Characteristics of restented patients
Age (yr)SexReason for restentingTumor location (stage)Stenosis locationDilatationStent type
62MProximal overgrowthGastric (T4)DistalNo6 cm, 20 mm CVRD
52MProximal overgrowthLung TmMiddleNo6 cm, 20 mm CVRD
54MProximal overgrowthGastric (T4)DistalAPC6 cm, 20 mm CVRD
71MProximal overgrowthEsophagus (T4)DistalNo6 cm, 20 mm CVRD
75MMigrationLung TmMiddleNo10 cm, 20 mm CVRD
53MProximal overgrowthEsophagus (T4)ProximalNo6 cm, 18 mm CVRD
64MMigrationEsophagus (T3)MiddleNo10 cm, 18 mm CVRD
67MMigrationEsophagus (T4)DistalNo10 cm, 20 mm UCVRD
55FProximal overgrowthGastric (T4)DistalNo15 cm, 20 mm CVRD
49FMigrationEsophagus (T4)DistalNo6 cm, 20 mm CVRD
Table 2 Patient demographics
n (%)
Total No. of patients90
Mean age (yr, range)61.57 (38-85)
Male/female65/25 (72.2/27.8)
Present illness
Esophagus carcinoma54 (60.0)
Squamous cell carcinoma47 (52.2)
Adenocarcinoma7 (7.7)
Gastric carcinoma (and cardiac)20 (22.2)
Lung carcinoma16 (17.7)
Location of obstruction
Proximal5 (5.6)
Middle31 (34.4)
Distal54 (60.0)
Restenting10 (11.1)
Table 3 Outcome of published series of self-expandable metallic stent insertion: with or without fluoroscopy for self-expandable metallic stent insertion
SeriesnDilation rate (%)Stents uncoveredPerforation rate (%)Migration rate (%)Overgrowth rate (%)Ingrowth rate (%)Reintervention rate (%)Median survival (d)
Present series9030.015/8504.46.63.315.5134
Wilkes et al[5]198895/503.125.5-39.8100
Adam et al[6]4210045/550192.39.53653
Knyrim et al[7]2210100/0009.514.23.8167
Sarper et al[8]4110019/814.92.42.42.4-94
Siersema et al[9]10070/10061310049109
Christie et al[10]1007776/2418.7429.151-
Wengrower et al[11]381-100/03.65.952.40-120
De Palma et al[12]2190100/000010.5-198
Kozarek et al[13]381005/95318.423.65.28090
White et al[14]17010057/432.801.42.8--
Maroju et al[15]130-9/9103710-161